Arthritis Research
Arthritis is an inflammatory disease of the joints, including the synovium, cartilage, bone, and supporting tissues. It is the leading cause of disability in the US and there are over 100 different types of the disease. The most common types of arthritis are osteoarthritis, rheumatoid arthritis and gout.
Arthritis Research Products Targets
- Matrix Metalloprotease (16)
- Cell Adhesion Molecule (21)
- Leukotriene and Related Receptor (13)
- Others (7)
- Glucocorticoid Receptor (9)
- Cyclooxygenase (24)
- Complement (2)
- Focal Adhesion Kinase (4)
- Chemokine CXC Receptor (9)
- Chemokine CC Receptor (13)
- p38 MAPK (16)
- Janus N-terminal Kinase (12)
- Calcium-Sensitive Protease Modulator (12)
- Rho-Kinases (9)
- NO donors and precursors (9)
- nNOS (5)
- iNOS (11)
- eNOS (1)
- Cytokine (15)
Products for Arthritis Research - Page 19
- Cat.No. Product Name Information/Activity
-
BCC6862
2-Iminopiperidine hydrochloride
16011-96-4
-
BCC6837
S-Isopropylisothiourea hydrobromide
4269-97-0
-
BCC6791
(S)-Methylisothiourea sulfate
867-44-7
-
BCC5706
L-NIL hydrochloride
150403-89-7
-
BCC7057
1400W dihydrochloride
1400W dihydrochloride is a potent and selective inhibitor of human inducible NO synthase with Ki values of 7 nM.
-
BCC7647
ARL 17477 dihydrochloride
866914-87-6
-
BCC6770
3-Bromo-7-nitroindazole
3-Bromo-7-nitroindazole is a more potent and selective inhibitor of neuronal nitric oxide synthase (nNOS) than eNOS or inducible nitric oxide synthase (iNOS). 3-Bromo-7-nitroindazole affects the intercellular messenger nitric oxide (NO) synthesis throughout the body and brain.
-
BCC5644
Pentamidine isethionate
Pentamidine isethionate (MP-601205 isethionate) is an antimicrobial agent and interferes with DNA biosynthetics. Pentamidine isethionate inhibits parasite Leishmania infantum with an IC50 of 2.5 μM. Pentamidine isethionate is a potent and selective protein tyrosine phosphatases (PTPases) and phosphatase of regenerating liver (PRL) inhibitor. Pentamidine isethionate has the potential for Gambian trypanosomiasis, antimony-resistant leishmaniasis, and Pneumocystis carinii pneumonia treatment. Antitumor and antibacterial activities.
-
BCC6965
Nω-Propyl-L-arginine hydrochloride
137361-05-8
-
BCC6762
N-Acetyl-N-acetoxy-4-chlorobenzenesulfonamide
142867-52-5


